Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's (Q33349465)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's |
scientific article |
Statements
1 reference
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's (English)
1 reference
Hans Konrad Muller-Hermelink
1 reference
Andreas Engert
1 reference
Petra Schiller
1 reference
Andreas Josting
1 reference
Richard Herrmann
1 reference
Peter Koch
1 reference
Markus Sieber
1 reference
Friederike Boissevain
1 reference
Maike De Wit
1 reference
Jorg Mezger
1 reference
Eckhart Duhmke
1 reference
Normann Willich
1 reference
Rolf-Peter Muller
1 reference
Bernhard F Schmidt
1 reference
Helmut Renner
1 reference
Beate Pfistner
1 reference
Jurgen Wolf
1 reference
Markus Loffler
1 reference
Volker Diehl
1 reference
German Hodgkin's Lymphoma Study Group
1 reference
11 August 2003
1 reference
1 reference
21
1 reference
19
1 reference
3601-3608
1 reference
Identifiers
1 reference
1 reference